Аннотация
Список литературы
Цель исследования – оценить значимость серологических маркеров воспалительного ответа в диагностике острого отторжения у пациентов после трансплантации печени.
Ключевые слова:
отторжение трансплантата печени
Interleukin-2, 8 and macrophage inflammatory protein-1html5-dom-document-internal-entity2-945-end levels in hepatic veins initially after reperfusion are associated with acute liver transplant rejection
The aim – of the study was to evaluate the association between different cytokines levels and acute liver transplant rejection.
Keywords
liver transplant rejection
- 1. Руммо, О. О. Cемь лет трансплантации печени в Республике Беларусь. Вестник трансплантологии и искусственных органов. Том 17, № 2 (2015): 100-104.
- 2. Andrea, R. Mueller, Klaus-Peter Platz, Bernd Kremer. Early postoperative complications following liver transplantation. BestPractice & Research Clinical Gastroenterology. 2004. Vol. 18, № 5. P. 881–900.
- 3. Song, AT et al. Liver transplantation: Fifty years of experience. World J Gastroenterol. 2014 May 14; 20 (18):5363-5374.
- 4. Shaked, A., Ghobrial R. M., Merion R. M. et al. Incidence and severity of acute cellular rejection in recipients undergoing adult living donor or deceased donor liver transplantation. Am. J. Transplant. 2009;9(2):301–308.
- 5. Millán, O. et al. Should IFN-γ, IL-17 and IL-2 be considered predictive biomarkers of acute rejection in liver and kidney transplant? Results of a multicentric study. Clinical Immunology (2014) 154, 141–154.
- 6. Mohammad Hossein Karimi et al. Study of the relationships between IL-23R, IL-17, IL-21 polymorphisms and serum level of IL-17, IL-21 with acute graft rejection in iranian liver transplant recipients. Immunol Invest, 2014; 43(1): 69–85
- 7. Hayato, Nakagawa et al. Impact of serum levels of IL-6 and adiponectin on all-cause, liver-related, and liver-unrelated mortality in chronic hepatitis C patients. J Gastroenterol. Hepatol. 2015 Feb;30(2):379-88. doi: 10.1111/jgh.12719.
- 8. Imagawa, D. K., Millis J. M., Olthoff K. M. et al. The role of tumor necrosis factor in allograft rejection. I. Evidence that elevated levels of tumor necrosis factor-alpha predict rejection following orthotopic liver transplantation. Transplantation. 1990; 50(2):219–225.
- 9. Hamilton, G., Prettenhofer M., Zommer A. et al. Intraoperative course and prognostic significance of endotoxin, tumor necrosis factor-alpha and interleukin-6 in liver transplant recipients. Immunobiology. 1991;182(5):425–439.
- 10. Imagawa, D. K., Millis J. M., Olthoff K. M. et al. The role of tumor necrosis factor in allograft rejection. II. Evidence that antibody therapy against tumor necrosis factor-alpha and lymphotoxin enhances cardiac allograft survival in rats. Transplantation. 1990; 50(2):189–193.
- 11. Tong, H., Chen K., Chen H. et al. Emodin prolongs recipient survival time after orthotopic liver transplantation in rats by polarizing the Th1/Th2 paradigm to Th2. Anat Rec (Hoboken). 2011;294(3):445–452.
- 12. Lai, X., Li J. Z., Lian Z. R. et al. Advantages of promoting interleukin-10 by silence of histone deacetylase 11 in inducing tolerance in orthotopic liver transplantation in rats. Transplant Proc. 2011;43(7):2728–2732.
- 13. Goralczyk, A. D., Hauke N., Bari N. et al. Interleukin 2 receptor antagonists for liver transplant recipients: a systematic review and metaanalysis of controlled studies. Hepatology. 2011; 54(2):541–554.
- 14. Ohzato, H., Monden M., Yoshizaki K. et al. Serum interleukin-6 levels as an indicator of acute rejection after liver transplantation in cynomologous monkeys. Surg Today. 1993; 23(6): 521–527.
- 15. Xie, X., Ye Y., Zhou L. et al. Kupffer cells promote acute rejection via induction of Th17 differentiation in rat liver allografts. Transplant Proc. 2010;42(9):3784–3792.
- 16. Yao, Z., Painter S. L., Fanslow W. C. et al. Human IL-17:a novel cytokine derived from T cells. J Immunol. 1995;155(12): 5483–5486.
- 17. Fabrega, E., Lopez-Hoyos M., San Segundo D. et al. Changes in the serum levels of interleukin-17/interleukin-23 during acute rejection in liver transplantation. Liver Transpl. 2009;15(6):629–633.